International Clinical Trial: Study on the effects and mechanisms of changes in population pharmacokinetics of elacycline under ECMO

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125249) titled 'Study on the effects and mechanisms of changes in population pharmacokinetics of elacycline under ECMO' on May 22.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Qilu Hospital of Shandong University

Condition: Carbapenem-resistant Gram-negative bacilli infections

Intervention: ECMO group:None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-08-04

Target Sample Size: ECMO group:50;Non-ECMO group:60;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=321117

Published by HT Digital Content Services wit...